Citigroup Inc Clearside Biomedical, Inc. Transaction History

Citigroup Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	BUY	$1.0 - $1.5 $37 - $55	37 Added 5.17%	752 $0
Q3 2022 Nov 10, 2022	SELL	$1.08 - $1.83 $219 - $371	-203 Reduced 22.11%	715 $1,000
Q2 2022 Aug 10, 2022	SELL	$1.3 - $2.49 $1,215 - $2,328	-935 Reduced 50.46%	918 $1,000
Q1 2022 May 12, 2022	SELL	$1.35 - $2.88 $10,813 - $23,068	-8,010 Reduced 81.21%	1,853 $4,000
Q4 2021 Feb 10, 2022	BUY	$2.72 - $5.72 $17,582 - $36,974	6,464 Added 190.17%	9,863 $27,000
Q3 2021 Nov 10, 2021	BUY	$4.83 - $7.2 $16,417 - $24,472	3,399 New	3,399 $20,000

13.4M

17.6K

100

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $61.4M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.